Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
26.88
+0.62 (2.36%)
Nov 14, 2024, 4:00 PM EST - Market closed
Tourmaline Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tourmaline Bio stock have an average target of 65, with a low estimate of 49 and a high estimate of 74. The average target predicts an increase of 141.82% from the current stock price of 26.88.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tourmaline Bio stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $49 | Strong Buy | Maintains | $48 → $49 | +82.29% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +78.57% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +78.57% | May 14, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +175.30% | Mar 25, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $41 → $72 | Strong Buy | Maintains | $41 → $72 | +167.86% | Mar 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
8.74M
EPS This Year
-3.09
from -8.87
EPS Next Year
-3.56
from -3.09
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 63.0M | 63.0M | ||
| Avg | n/a | 8.7M | 10.2M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 620.6% | ||
| Avg | - | - | 16.7% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.87 | -1.76 | -2.99 | ||
| Avg | -3.09 | -3.56 | -4.07 | ||
| Low | -3.68 | -4.51 | -4.83 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.